Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-038852

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Donald E Bobo Jr.
Officer — CVP, Heart Valve Therapy
Period of report
Sep 2, 2016
Accepted (ET)
Sep 6, 2016 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Sep 2, 2016M20,000$25.48A64,901D
Common StockF3,F2Sep 2, 2016S18,000$115.7805D46,901D
Common StockF4holding———12,350I401(k)

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F5$25.48Sep 2, 2016M20,000DMay 13, 2011May 12, 2017Common Stock20,000113,600D

Explanation of responses